secwatch / observer
8-K filed December 17, 2025, 6:59 PM ET ticker ASTC CIK 0001001907
other material confidence high sentiment neutral materiality 0.35

Astrotech extends poison pill to Dec 2026; annual meeting elects directors

ASTROTECH Corp

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.95

ASTROTECH Corp issued securities.

Exact text from the filing
On December 12, 2025, the Company entered into Amendment No. 3 to the Rights Agreement with the Rights Agent (the “Amendment”), which amends the Rights Agreement. The Amendment extends the Final Expiration Date (as defined in the Rights Agreement) to 5:00 P.M., New York City time, on December 20, 2026, unless the Final Expiration Date is further extended by the Company or the rights subject to the Rights Agreement (the “Rights”) are earlier redeemed or exchanged by the Company in accordance with the terms of the Rights Agreement.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

ASTROTECH Corp amended Rights Agreement with Equiniti Trust Company (f/k/a American Stock Transfer & Trust Company, LLC) valued at Extends Final Expiration Date to 5:00 P.M., New York City time, on December 20, 2026 (effective 2025-12-12).

Action
amendment
Counterparty
Equiniti Trust Company (f/k/a American Stock Transfer & Trust Company, LLC)
Value
Extends Final Expiration Date to 5:00 P.M., New York City time, on December 20, 2026
Effective
2025-12-12
Exact text from the filing
On December 12, 2025, the Company entered into Amendment No. 3 to the Rights Agreement with the Rights Agent (the “Amendment”), which amends the Rights Agreement.
View on SEC.gov

32 equity issuances filed in the last 30 days. Browse all equity issuances →

ASTROTECH Corp filing history →

Source: SEC EDGAR
accession 0001437749-25-038149
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.